ToolGen, Inc., Demonstrates CRISPR/cas9 Gene Editing Improves Anti-Tumor Activity of Human CAR-T Cells – GlobeNewswire (press release)
ToolGen, Inc., Demonstrates CRISPR/cas9 Gene Editing Improves Anti-Tumor Activity of Human CAR-T CellsGlobeNewswire (press release)The poster, entitled “CRISPR/Cas9-Mediated Knockout of DGK Improves Anti-Tumor Activities of Human T Cells” (Abst. #114),… Continue reading
